文献速递泌尿生殖MR

基于MRI定量风险图诊断前列腺癌的可行性研究

Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study.
PubMed 文献 · AJR Am J Roentgenol · 2019-04-30

本研究纳入30例经活检证实的前列腺癌患者,术前接受3-T多参数MRI,基于体素计算ADC、T2和DCE信号增强率并加权生成0-100的最终风险评分,用5例训练集确定阈值、25例验证集进行病灶和分区分析,结果显示风险图工具对临床显著癌(≥Gleason 3+4)敏感度89.2%,分区分析AUC为0.84,结论认为该工具能有效检出临床显著前列腺癌。

要点

  • 风险评分加权为ADC 40%、T2 40%、DCE 20%,高风险对应低T2、低ADC和高信号增强率。
  • 对临床显著癌(≥Gleason 3+4)敏感度89.2%,对索引病灶敏感度100%,对所有病灶敏感度76.6%。
  • 分区分析检出前列腺癌的敏感度78.9%、特异度88.5%、AUC 0.84。

核心结论

  • 风险分析工具在外周带和移行带均能以合理的敏感度和特异度检出临床显著前列腺癌。

研究设计与样本

  • 可行性研究,纳入30例经活检证实前列腺癌并接受术前3-T多参数MRI的患者。
  • 以体素为单位计算全前列腺ADC、T2和DCE信号增强率(α)并配准,生成0-100的归一化风险值。
  • 最终风险评分为各参数风险评分的加权和:ADC 40%、T2 40%、DCE 20%。
  • 5例患者数据作为训练集确定预测前列腺癌的阈值,其余25例用于验证。
  • 验证集中,最终风险评分高于阈值且至少含30个连续体素(约4.8 mm²)的区域判为癌阳性。

诊断标准与关键数值

  • 高风险值对应低T2、低ADC和高信号增强率,归一化风险值范围0-100。
  • 最终风险评分=ADC风险评分×40%+T2风险评分×40%+DCE风险评分×20%。
  • 病灶分析敏感度:所有病灶76.6%,临床显著病灶(≥Gleason 3+4)89.2%,索引病灶100%。
  • 分区分析检出所有病灶的敏感度78.9%、特异度88.5%、阳性预测值84.4%、阴性预测值84.1%,ROC AUC 0.84。
  • 阳性判定标准为最终风险评分高于训练集确定的阈值且至少30个连续体素(约4.8 mm²)。

临床应用与阅片要点

  • 阅片时可参考以ADC 40%、T2 40%、DCE 20%加权生成的0-100风险图,高风险区域对应低T2、低ADC和高信号增强率。
  • 工具对索引病灶和临床显著癌敏感度较高,对外周带和移行带均适用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to develop a new quantitative image analysis tool for estimating the risk of cancer of the prostate by use of quantitative multiparametric MRI (mpMRI) metrics. MATERIALS AND METHODS. Thirty patients with biopsy-confirmed prostate cancer (PCa) who underwent preoperative 3-T mpMRI were included in the study. Quantitative mpMRI metrics-apparent diffusion coefficient (ADC), T2, and dynamic contrast-enhanced (DCE) signal enhancement rate (α)-were calculated on a voxel-by-voxel basis for the whole prostate and coregistered. A normalized risk value (0-100) for each mpMRI parameter was obtained, with high risk values associated with low T2 and ADC and high signal enhancement rate. The final risk score was calculated as a weighted sum of the risk scores (ADC, 40%; T2, 40%; DCE, 20%). Data from five patients were used as training set to find the threshold for predicting PCa. In the other 25 patients, any region with a minimum of 30 con-joint voxels (≈ 4.8 mm2) with final risk score above the threshold was considered positive for cancer. Lesion-based and sector-based analyses were performed by matching prostatectomyverified malignancy and PCa predicted with the risk analysis tool. RESULTS. The risk map tool had sensitivity of 76.6%, 89.2%, and 100% for detecting all lesions, clinically significant lesions (≥ Gleason 3 + 4), and index lesions, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for PCa detection for all lesions in the sector-based analysis were 78.9%, 88.5%, 84.4%, and 84.1%, respectively, with an ROC AUC of 0.84. CONCLUSION. The risk analysis tool is effective for detecting clinically significant PCa with reasonable sensitivity and specificity in both peripheral and transition zones.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chatterjee A, He D, Fan X, et al. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study. AJR Am J Roentgenol. 2019. PMID: 31039019. doi:10.2214/AJR.18.20702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。